CSX heads into its May 12 earnings call riding a strong price recovery — but shorts have quietly rebuilt positions all month, even as the Street turned more bullish after a standout Q1 print.
The analyst reaction to Q1 was broad and decisive. Every firm that updated targets moved them higher, not a single cut among the ten who published within 24 hours of the April 22 release. Wells Fargo lifted its target the most — from $40 to $50 — while maintaining Overweight. Baird, RBC, and Barclays each moved to $47. Goldman Sachs, the most cautious voice in the group, raised its target from $37 to $41 but held its Neutral rating, and Citigroup did the same, going to $46 with no change to Neutral. The message from bulls is clear: Q1 demonstrated that intermodal and chemical volumes can offset coal headwinds, and pricing is holding. Bears point to structural risks — export coal in long-term decline, low natural gas prices crowding out demand, and competitive pressure from trucking technology — that the quarterly beat does not resolve.
Short interest tells a more cautious story despite the price strength. Bears quietly added exposure through April: short interest as a percentage of the free float climbed from roughly 1.9% in late March to 2.25% now — a 31% increase over the month — even as the stock rallied 14%. That is an unusual combination. Borrow conditions remain easy, with cost to borrow running below 0.5% and availability loose, so there is no friction stopping further short building. The ORTEX short score of 33.5 is not extreme, but it has drifted gradually higher over the past two weeks. This does not look like a crowded short; it looks like measured re-engagement from sellers who think the post-earnings bounce has run its course.
Options pricing has also cooled from its most defensive reading. The put/call ratio hit 1.36 on April 24 — matching the 52-week high — before retreating to 1.08 by end of the week. The 20-day average is 1.01, so current positioning is only modestly skewed toward protection, with a z-score near 0.46. That suggests options traders stepped in defensively around the Q1 release and have since partially unwound those hedges. The moderation in PCR is consistent with relief rather than conviction; the stock's 4.3% weekly gain and 14% monthly recovery have taken some of the urgency out of downside hedging.
One insider move stands out in the recent history. CEO Stephen Angel bought 25,000 shares on March 6 at $40.27, a $1 million purchase at a price well below today's levels. The remaining insider activity in February was routine tax-related selling from multiple C-suite officers at similar prices. Over the 90-day window, net insider activity is modestly positive — about $9.6 million net — with Angel's purchase the only discretionary buy. It is a small flag, but notable given the timing: the CEO bought near the lows before the stock's biggest recovery run of the year.
Rail peers moved in a tight pack on the week. UNP gained 6.6% and NSC 4.8%, closely tracking CSX's 4.3% rise — all three gave back a fraction on the final day of the week. The sector-wide recovery reflects broader macro relief rather than CSX-specific momentum, which makes the short rebuilding even more notable: if the whole sector is recovering, sellers are specifically choosing CSX as the vehicle.
The next focal point is the May 12 earnings call. After a 6.5% jump following Q1 results, the question is whether volume trends in intermodal and chemicals have sustained the momentum — or whether the April trade uncertainty weighed on bookings in ways not yet visible in the price.
See the live data behind this article on ORTEX.
Open CSX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
